Form 8-K - Current report:
SEC Accession No. 0001628280-23-003635
Filing Date
2023-02-15
Accepted
2023-02-15 08:34:46
Documents
17
Period of Report
2023-02-10
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arwr-20230210.htm   iXBRL 8-K 39840
2 EX-99.1 nr-xjnjx0795aroxpnpla3ri.htm EX-99.1 10650
6 nr-xjnjx0795aroxpnpla3ri001.jpg GRAPHIC 186027
7 nr-xjnjx0795aroxpnpla3ri002.jpg GRAPHIC 203249
8 nr-xjnjx0795aroxpnpla3ri003.jpg GRAPHIC 263617
9 nr-xjnjx0795aroxpnpla3ri004.jpg GRAPHIC 85927
  Complete submission text file 0001628280-23-003635.txt   1215096

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arwr-20230210.xsd EX-101.SCH 1929
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arwr-20230210_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arwr-20230210_pre.xml EX-101.PRE 13064
11 EXTRACTED XBRL INSTANCE DOCUMENT arwr-20230210_htm.xml XML 11265
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 23633751
SIC: 2834 Pharmaceutical Preparations